Medical Science News

RSS

Inhaled living medicine reduces drug-resistant lung biofilms in the lungs of pigs

A "living medicine" has thinned biofilms of antibiotic-resistant Pseudomonas aeruginosa in the lungs of pigs, according to the findings of a study published today in the journal eBioMedicine.

12 Nov 2026

Sleep-like brain waves during wakefulness linked to Parkinson's symptoms

A new study shows that slow brain waves – typically associated with deep sleep or a sleep-like state – are more frequent during wakefulness in patients with Parkinson's disease and correlate with symptoms such as hallucinations and impaired cognition.

12 Nov 2026

Immune and metabolic shifts drive acute pancreatitis into chronic disease

Pancreatitis is clinically classified into acute pancreatitis (AP) and chronic pancreatitis (CP). Most patients with AP recover without residual pancreatic dysfunction; a subset develops recurrent AP, and only selected high-risk individuals-particularly those with ongoing etiological exposure, genetic susceptibility, or severe necrotizing disease-progress to CP.

12 Nov 2026

Extreme heat stops athletes from fully using carbohydrates for fuel

Endurance sport has seen a renaissance in the understanding of carbohydrates for fuel in recent years. Advances in sports science have led to much higher levels of carbohydrates either eaten or drunk during exercise, with some top sports stars consuming 120g or more per hour during a race.

12 Nov 2026

New salt-triggered gel makes bacterial cancer therapy much safer

The abdominal cavity is salty enough to set a gel. On that trick rests a delivery system reported in The Innovation: a small molecule that stays liquid in the syringe and, meeting sodium in the peritoneum, gels within a minute.

12 Nov 2026

Muscle benefits of lifting weights while taking tirzepatide

Resistance training alongside tirzepatide helped adults with obesity retain more lean tissue and gain strength without reducing weight-loss benefits.

12 Nov 2026

Researchers uncover how surrounding cells fuel triple-negative breast cancer growth

Triple-negative breast cancer, which accounts for approximately 10–15% of all breast cancer cases, is considered particularly difficult to treat because it grows rapidly and carries a high risk of recurrence.

12 Nov 2026

Researchers identify promising new immune target for treating endometriosis

Affecting 200 million women of reproductive age, endometriosis is a chronic inflammatory disease that causes pain, infertility, and increased ovarian cancer risk.

12 Nov 2026

A pain in the neck? New Adelaide University trial offers hope

Whether you hunch over a computer or spend hours scrolling on your phone, everyday habits can be a real pain in the neck. But when that pain persists, it can take a serious toll on everyday life, affecting everything from work and sleep to physical activity and wellbeing.

12 Nov 2026

Phone reminders stop nighttime snacking, but not for long

An after dinner or bedtime snack can be hard to resist, but could a gentle nudge from a smartphone app help people with type two diabetes to quit the common habit?

12 Nov 2026

Orexo and SVF Vaccines collaborate to explore AmorphOX® formulation of LNP-mRNA vaccines

Orexo AB and SVF Vaccines AB today announced a research collaboration to investigate whether Orexo’s proprietary powder-based drug delivery technology, AmorphOX®, can be used to develop stable powder-based formulations of lipid nanoparticle (LNP)-encapsulated messenger RNA (mRNA) vaccines.

12 Nov 2026

Richmond Pharmacology highlights encouraging first-in-human results for Regeneron's investigational RNAi therapy in MASLD

Richmond Pharmacology, a specialist early-phase clinical research organization, has announced encouraging results from a first-in-human clinical trial evaluating CIDEBsiRNA, an investigational RNA interference (RNAi) therapy developed by Regeneron Pharmaceuticals, Inc.

12 Nov 2026

Ephrin-B1 phosphorylation disrupts nephrin complexes in nephrotic syndrome pathogenesis

A group led by the Department of Cell Biology at the Kidney Research Center, Niigata University identified a novel Ca2+-independent pathogenic mechanism of nephrotic syndrome.

12 Nov 2026

New method reveals how individual glioblastoma cells spread through the brain

By combining live imaging of brain tissue with artificial intelligence, researchers at Uppsala University have developed a method that reveals how individual glioblastoma cells spread through the brain, how they can switch between different ways of moving, and how they are affected by cancer treatments. An

12 Nov 2026

Type 2 diabetes accelerates jawbone loss and causes tooth loss

Type 2 diabetes (T2D) is a chronic metabolic disorder whose global burden continues to rise. Beyond its systemic effects, T2D compromises skeletal health and markedly worsens loss of alveolar bone—the bone that anchors teeth—leading to tooth loosening, increased mobility, and eventual tooth loss.

11 Nov 2026

Environmental experiences trigger widespread changes in brain cell connections

Experiences and changes in environment cause widespread alterations in connections between brain cells, influencing brain activity, research suggests.

11 Nov 2026

BNP hormone may actively promote blood clot formation, study finds

A hormone found in the blood and long viewed as a biological "check engine light" may do more than signal cardiovascular distress, according to researchers with the Texas A&M University Irma Lerma Rangel College of Pharmacy at Texas A&M Health.

11 Nov 2026

Declining thermogenic fat activity may explain age-related cold sensitivity

Researchers from City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the country, have uncovered the biological reason for why we become more sensitive to cold as we get older.

11 Nov 2026

New molecular approach shows promise against treatment-resistant prostate cancer

Many modern cancer drugs typically target a specific protein or signaling pathway to treat tumors.

11 Nov 2026

$7.2 million NIH funding supports research into long-lived plasma cells

Central to many immune responses are antibodies, which identify foreign substances and help remove them from the body. The immune cells that produce them are called plasma cells, and they can mature into long-lived plasma cells that persist and provide protection for years or even decades.

11 Nov 2026